Search

Author/Creator Godfraind, C.

1. A polyphenotypic malignant paediatric brain tumour presenting a MN1‐PATZ1 fusion, no epigenetic similarities with CNS High‐Grade Neuroepithelial Tumour with MN1 Alteration (CNS HGNET‐MN1) and related to PATZ1‐fused sarcomas. (3rd June 2020)

Authors:
Burel‐Vandenbos, F.; Pierron, G.; Thomas, C.; Reynaud, S.; Gregoire, V.; Duhil de Benaze, G.; Croze, S.; Chivoret, N.; Honavar, M.; Figarella‐Branger, D.; Maurage, C.‐A.; Pedeutour, F.; Hasselblatt, M.; Godfraind, C.
Journal:
Neuropathology & applied neurobiology
Issue:
Volume 46:Number 5(2020)
Page Start:
506
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Meningeal SWI/SNF related, matrix‐associated, actin‐dependent regulator of chromatin, subfamily B member 1 (SMARCB1)‐deficient tumours: an emerging group of meningeal tumours. (28th December 2016)

Authors:
Dadone, B.; Fontaine, D.; Mondot, L.; Cristofari, G.; Jouvet, A.; Godfraind, C.; Varlet, P.; Ranchère‐Vince, D.; Coindre, J.‐M.; Gastaud, L.; Baudoin, C.; Peyron, A.‐C.; Thyss, A.; Coutts, M.; Michiels, J.‐F.; Pedeutour, F.; Burel‐Vandenbos, F.
Journal:
Neuropathology & applied neurobiology
Issue:
Volume 43:Number 5(2017)
Page Start:
433
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Phase 1 trial of ralimetinib (LY2228820) with radiotherapy plus concomitant temozolomide in the treatment of newly diagnosed glioblastoma. (January 2021)

Authors:
Biau, J.; Thivat, E.; Chautard, E.; Stefan, D.; Boone, M.; Chauffert, B.; Bourgne, C.; Richard, D.; Molnar, I.; Levesque, S.; Bellini, R.; Kwiatkowski, F.; Karayan-Tapon, L.; Verrelle, P.; Godfraind, C.; Durando, X.
Journal:
Radiotherapy and oncology
Issue:
Volume 154(2021)
Page Start:
227
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗